Laws
-
Working Paper Series
US Pharma’s Financialized Business Model
Jul 2017
Price gouging in the US pharmaceutical drug industry goes back more than three decades.
-
Working Paper Series
The Functions of the Stock Market and the Fallacies of Shareholder Value
Jun 2017
Conventional wisdom has it that the primary function of the stock market is to raise cash for companies for the purpose of investing in productive capabilities. The conventional wisdom is wrong.
-
It’s Not Just Profit Wrecking American Healthcare
May 15, 2017
A look at America’s strange and dangerous approach to medicine, and how to fix it
-
Making Innovation Work for China and other Developing Countries
Apr 12, 2017
Along the entire “innovation chain” — from research and development, to production and commercialization — government and private sectors have very different roles to play.
-
Jayadev: TPP is Dead, but its Legacy Lives On
Feb 10, 2017
Institute scholar Arjun Jayadev argues that while TPP is dead, its damaging legacy on intellectual property rights is likely to shape future bilateral trade agreements
-
The Retreat from Hyper-Globalization
Dec 1, 2016
Flows of goods and services, people and capital have overwhelmed the ability of political processes to accommodate them
-
Lazonick links stock buybacks to America’s jobs challenge
Nov 4, 2016
In an Al Jazeera documentary “In Search of the Great American Job”, Institute scholar William Lazonick offers some arch insights into the relationship between financialization — particularly the “shareholder value” ideology in corporations, which drives the transfer of profits to shareholders through stock buybacks — and job creation and inequality.
-
Inequality As Policy: Selective Trade Protectionism Favors Higher Earners
Oct 27, 2016
Offshoring manufacturing may have hurt many working people in America, but professionals and intellectual property have been robustly protected
-
U.S. Corporations Don’t Need Tax Breaks on Foreign Profits
Dec 21, 2015
Many Americans have expressed outrage over Pfizer’s plan, through its merger with Allergan, to move its tax home from the United States to Ireland. Now, in a New York Times op-ed, Carl Icahn, the billionaire corporate raider turned hedge fund activist, has joined the chorus. He labels the Pfizer-Allergan deal a “travesty,” blaming the U.S.’s “uncompetitive international tax system.”
-
Global Tax Dodging Just One Part of Pfizer’s Corrupt Business Model
Dec 3, 2015
Why are we paying for corporate behavior that crushes innovation, cheats taxpayers, cost jobs, and heightens inequality?
-
Big Finance, Demystified
Oct 8, 2015
John Kay shares findings from his new book, Other People’s Money, and his insights on changing the financial sector.
-
Upholding the Rule of Law
Apr 13, 2015
Here we are, some 7 years after the Great Financial Crisis, and not one senior banking executive has gone to jail.
-
Conference paper
Reflexivity, expectations feedback and almost self-fulfilling equilibria: economic theory, empirical evidence and laboratory experiments
Apr 2015
We discuss recent work on bounded rationality and learning in relation to Soros’ principle of reflexivity and stress the empirical importance of non-rational, almost self-fulfilling equilibria in positive feedback systems.
-
Years granted:
2015
Copyrights and Creativity: Historical Evidence from Literature, Science, and Music
This research project improves our understanding of the effects of intellectual property rights—and in particular copyrights—on creativity and innovation.
-
Working Paper Series
Wage Increases, Transfers, and the Socially Determined Income Distribution in the USA
Apr 2014
This paper is based on a social accounting matrix (SAM) which incorporates the size distribution of income based on data from the BEA national accounts, the widely discussed 2012 CBO distribution study, and BLS consumer surveys.